Insider · CIK 0001994071
Max Rosett
Files at IMNM (Immunome Inc.). First filing Sep 20, 2024, latest Jun 17, 2026.
In brief
Max Rosett files SEC Form 4 as CFO at IMNM (Immunome Inc.). Since Sep 20, 2024, Max Rosett has reported 0 open-market buys worth $0 and 3 open-market sells worth $2.7M, the latest filed on Jun 17, 2026.
A track record needs three past buys with six months of prices behind them; Max Rosett has 0, so none is measured yet.
The newest scored trade: sold $1.1M of IMNM on Jun 15, 2026, filed Jun 17, 2026, scored 47 (moderate), under a 10b5-1 plan. In the last 12 months: 0 buys worth $0 and 2 sells worth $2.5M.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
IMNM: Immunome Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 47Moderate | Immunome Inc. | $1.1M 60,000 shares | -53% | +115% from low-33% from high | |
| 47Moderate | Immunome Inc. | $1.4M 65,000 shares | -55% | +293% from low-19% from high | |
| 25Weak | IMNMsell Immunome Inc. | $230k 14,380 shares | -23% | +118% from low-44% from high |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Jun 15, 2026 | IMNM Immunome Inc. | 60,000 0.05% of outstanding | $1.1M | Jun 15, 2026 | $1.4M |
| Apr 2, 2026 | IMNM Immunome Inc. | 65,000 0.06% of outstanding | $4.7M | Apr 2, 2026 | none |
| Sep 19, 2024 | IMNM Immunome Inc. | 14,380 0.02% of outstanding | $230k | Sep 19, 2024 | none |
Transactions
Every row this insider has filed, 18 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jul 23, 2026 | IMNM Immunome Inc. | AGrant or award Common Stock | +47,250 | $0.00 | $0 | 101,287 | Jul 27, 2026 |
| Jul 23, 2026 | IMNM Immunome Inc. | AGrant or award Employee Stock Option (right to buy)derivative | +94,500 | $0.00 | $0 | 94,500 | Jul 27, 2026 |
| Jun 15, 2026 | IMNM Immunome Inc. | MOption exercise Common Stock10b5-1 | +60,000 | $1.05 | $63k | 114,037 | Jun 17, 2026 |
| Jun 15, 2026 | IMNM Immunome Inc. | SOpen-market sale Common Stock10b5-1 | -60,000 | $18.23 | $1.1M | 54,037 | Jun 17, 2026 |
| Jun 15, 2026 | IMNM Immunome Inc. | MOption exercise Stock Option (right to buy)derivative10b5-1 | -60,000 | $0.00 | $0 | 0 | Jun 17, 2026 |
| Apr 2, 2026 | IMNM Immunome Inc. | MOption exercise Common Stock10b5-1 | +31,848 | $1.05 | $33k | 79,324 | Apr 3, 2026 |
| Apr 2, 2026 | IMNM Immunome Inc. | MOption exercise Common Stock10b5-1 | +39,713 | $1.35 | $54k | 119,037 | Apr 3, 2026 |
| Apr 2, 2026 | IMNM Immunome Inc. | SOpen-market sale Common Stock10b5-1 | -63,656 | $21.91 | $1.4M | 55,381 | Apr 3, 2026 |
| Apr 2, 2026 | IMNM Immunome Inc. | SOpen-market sale Common Stock10b5-1 | -1,344 | $22.48 | $30k | 54,037 | Apr 3, 2026 |
| Apr 2, 2026 | IMNM Immunome Inc. | MOption exercise Stock option (right to buy)derivative10b5-1 | -31,848 | $0.00 | $0 | 60,000 | Apr 3, 2026 |
| Apr 2, 2026 | IMNM Immunome Inc. | MOption exercise Stock option (right to buy)derivative10b5-1 | -39,713 | $0.00 | $0 | 0 | Apr 3, 2026 |
| Jul 29, 2025 | IMNM Immunome Inc. | AGrant or award Employee Stock Option (right to buy)derivative | +207,000 | $0.00 | $0 | 207,000 | Jul 31, 2025 |
| Sep 19, 2024 | IMNM Immunome Inc. | MOption exercise Common Stock | +42,000 | $1.05 | $44k | 61,856 | Sep 20, 2024 |
| Sep 19, 2024 | IMNM Immunome Inc. | SOpen-market sale Common Stock | -14,380 | $16.01 | $230k | 47,476 | Sep 20, 2024 |
| Sep 19, 2024 | IMNM Immunome Inc. | MOption exercise Stock option (right to buy)derivative | -42,000 | $0.00 | $0 | 91,848 | Sep 20, 2024 |
| Aug 9, 2024 | IMNM Immunome Inc. | AGrant or award Stock option (right to buy)derivative | +190,000 | $0.00 | $0 | 190,000 | Aug 13, 2024 |
| May 16, 2024 | IMNM Immunome Inc. | AGrant or award Stock option (right to buy)derivative | +30,000 | $0.00 | $0 | 30,000 | May 17, 2024 |
| Jan 31, 2024 | IMNM Immunome Inc. | AGrant or award Stock option (right to buy)derivative | +175,000 | $0.00 | $0 | 175,000 | Jan 31, 2024 |
Questions about Max Rosett
Answered from the filings on this page, as of the latest one.
Is Max Rosett buying or selling?
In the last 12 months Max Rosett reported 0 open-market buys worth $0 and 2 open-market sells worth $2.5M on SEC Form 4; the latest was sold $1.1M of IMNM on Jun 15, 2026. Grants, option exercises and tax withholding are not counted.
How did Max Rosett's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Max Rosett has 0.
Where does Max Rosett file Form 4?
Max Rosett has filed Form 4 at IMNM (Immunome Inc.) as Chief Financial Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.